Zusammenfassung
Bei Patienten mit vorbestehender Leberzirrhose zeigt sich auch im Rahmen nichthepatobiliär-chirurgischer (N-HPB-)Interventionen ein hohes perioperatives Mortalitäts- und Morbiditätsrisiko infolge eines postoperativen Leberversagens (PLV). Daher sind bei diesem Patientengut, unabhängig von der chirurgischen Fachspezifität, Prävention, Diagnostik und etwaige Therapie des PLV essenziell. Derzeit existiert für N-HPB-Operationen keine einheitliche Definition des PLV. In Analogie zur Definition des PLV durch die International Study Group of Liver Surgery (ISGLS) stellen die progressive Hyperbilirubinämie und Koagulopathie ab dem 5. postoperativen Tag die Kerncharakteristika des PLV dar. Die Child-Turcotte-Pugh-(CTP)-Klassifikation und der Model for End-Stage Liver Disease (MELD) Score sind geeignete Instrumente zur Abschätzung des prospektiven perioperativen Risikos und sollten in die operationsstrategische Planung miteinfließen. Die ISGLS-Klassifikation ist für die postoperative Diagnostik und Behandlung des PLV geeignet. Die Therapie des PLV stellt eine große Herausforderung dar, da derzeit keine kausalen Ansätze existieren und diese lediglich symptomorientiert erfolgt. Daher ist die Prävention des PLV unter Zuhilfenahme eines erfahrenen Hepatologen essenziell.
Abstract
Patients with preexisting cirrhosis who are subjected to hepatobiliary (HBP) or non-hepatobiliary (N-HBP) surgery are expected to bear an exceptionally high risk of morbidity and mortality due to postoperative liver failure (PLV). Therefore, thorough clinical diagnostics, prevention and adequate management of PLV are pivotal for a good outcome irrespective of the type of surgery applied in this particular group of patients. To date there is no standard definition used for PLV. In accordance with International Study Group of Liver Surgery (ISGLS) definition, progressive hyperbilirubinemia and coagulopathy after postoperative day 5 represent the main characteristics implicating PLV. The Child-Turcotte-Pugh (CTP) classification and the model for end-stage liver disease (MELD) score allow a reliable estimation of the perioperative risk and thus provide a useful assistance in planning surgery. The ISGLS classification is helpful in the postoperative diagnosis and treatment of PLV. The treatment of PLV is extremely challenging and limited to counteracting symptoms with no option to cure the underlying liver disease.
Literatur
Alfieri S, Carriero C, Caprino P et al (2001) Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed. Dig Liver Dis 33:341–346
Aranha GV, Sontag SJ, Greenlee HB (1982) Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg 143:55–60
Azoulay D, Castaing D, Krissat J et al (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665–672
Balzan S, Belghiti J, Farges O et al (2005) The „50–50 criteria“ on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828
Behrns KE, Tsiotos GG, DeSouza NF et al (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292–298
Chandok N, Watt KD (2010) Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc 85:451–458
Chiu A, Chan LM, Fan ST (2006) Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 26:695–702
Coelho JC, Claus CM, Machuca TN et al (2004) Liver resection: 10-year experience from a single institution. Arq Gastroenterol 41:229–235
Csikesz NG, Nguyen LN, Tseng JF, Shah SA (2009) Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg 208:96–103
Cucchetti A, Ercolani G, Cescon M et al (2006) Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 203:670–676
Friedman LS (2010) Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc 121:192–204
Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–691
Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206
Jalan R, Olde Damink SW, Hayes PC et al (2004) Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41:613–620
McDonald DM, Thurston G, Baluk P (1999) Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 6:7–22
Nicoll A (2012) Surgical risk in patients with cirrhosis. J Gastroenterol Hepatol 27:1569–1575
Panis Y, McMullan DM, Emond JC (1997) Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 121:142–149
Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724
Schroeder RA, Marroquin CE, Bute BP et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373–379
Shaheen AA, Kaplan GG, Hubbard JN, Myers RP (2009) Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int 29:1141–1151
Tanaka K, Kumamoto T, Matsuyama R et al (2010) Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 14:359–368
Telem DA, Schiano T, Divino CM (2010) Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. Surgery 148:538–543
Tsien CD, McCullough AJ, Dasarathy S (2012) Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 27:430–441
Van de Kerkhove MP, de Jong KP, Rijken AM et al (2003) MARS treatment in posthepatectomy liver failure. Liver Int 3:44–51
Vallance P, Moncada S (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 30:776–778
Warnick P, Mai I, Klein F et al (2011) Safety of pancreatic surgery in patients with simultaneous liver cirrhosis: a single center experience. Pancreatology 11:24–29
Wilms C, Mueller L, Lenk C et al (2008) Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 247:825–834
Einhaltung ethischer Richtlinien
Interessenkonflikt. C. Wilms, A. Radtke, S. Beckebaum, V. Cicinatti und H.J. Schmidt geben an, dass kein Interessenkonflikt besteht. Der Beitrag enthält keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilms, C., Radtke, A., Beckebaum, S. et al. Prävention und Therapie des postoperativen Leberversagens. Z Herz- Thorax- Gefäßchir 28, 216–221 (2014). https://doi.org/10.1007/s00398-014-1080-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00398-014-1080-0